Fitbit received clearance from the U.S. Food and Drug Administration for our new PPG (photoplethysmography) algorithm to identify atrial fibrillation (AFib). The algorithm will power our new Irregular Heart Rhythm Notifications feature on Fitbit.
News | Wearables
New Fitbit Feature Makes AFib Detection More Accessible

April 12, 2022 — Fitbit received clearance from the U.S. Food and Drug Administration for its new PPG ...

Home April 12, 2022
Home
Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute at Cedars-Sinai and the Mark S. Siegel Family Foundation Distinguished Professor
News | Heart Failure
Cell-Derived Therapy May Help Repair Abnormal Heart Rhythm

April 12, 2022 — Vesicles secreted from human heart cells may repair damaged tissue and prevent lethal heart rhythm ...

Home April 12, 2022
Home
 Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include coronary use.
News | Guidewires
FDA Clears Four New Coronary Micro Support Catheters

April 12, 2022 — Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include ...

Home April 12, 2022
Home
Radiation to the heart during treatment for locally advanced lung cancer is associated with an increased risk of major adverse cardiac events within the first two years following treatment. The higher the cardiac dose exposure, the higher the risk of a cardiac event.
News | Cardiac Imaging
Simple Changes in Care Reduced Heart Exposure During Lung Cancer Radiation Treatment

April 11, 2022 — Radiation to the heart during treatment for locally advanced lung cancer is associated with an ...

Home April 11, 2022
Home
Physicians prescribed significantly more guideline-directed medications for heart failure if they received a customized digital alert via an electronic health record (EHR) system when inputting medical orders shortly after seeing a patient, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | Heart Failure
Electronic Alert Improves Guideline Adherence for Heart Failure Treatment

April 8, 2022 – Physicians prescribed significantly more guideline-directed medications for heart failure if they ...

Home April 08, 2022
Home
Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | Heart Failure
Patiromer Helps Patients Stay on Optimal Heart Failure Therapy
April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...
Home April 08, 2022
Home
Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five years compared with similar patients who had the biologic valve inserted surgically.
News | Structural Heart
Rate of Structural Valve Deterioration Lower with TAVR than with SAVR
April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less ...
Home April 08, 2022
Home
The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing improvements in quality care delivery for heart attacks in low- and middle-income countries with the use of data collection and localized education around guideline-directed medical therapy, according to data from the program’s second year.
News | STEMI
ACC Program sees Improvement in Global Heart Attack Care

April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing ...

Home April 07, 2022
Home
ADAPT-TAVR Trial
News | Structural Heart
No Reduction in Stroke, Mini Strokes, Blood Clotting in the Brain or Changes in Cognitive Function with Edoxaban After TAVR

April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...

Home April 07, 2022
Home
Tricuspid valve
News | Cardiovascular Clinical Studies
Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...

Home April 07, 2022
Home
Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, during and for up to two days after surgery made no difference in the rates of major cardiovascular events in the 30 days following surgery.
News | Hypertension
Blood Pressure Management Strategy During Surgery Has No Impact on Major Cardiovascular Complications

April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a ...

Home April 07, 2022
Home
While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or “bad” cholesterol, and other lipids, to date there are no approved treatments to lower lipoprotein(a), a lesser-known driver of heart disease risk.
News | Cardiovascular Clinical Studies
SLN360 Markedly Reduces Lipoprotein(a), an Important Cause of Heart Disease

April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...

Home April 06, 2022
Home
Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).
News | Implantable Cardiac Monitor (ICM)
Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...
Home April 06, 2022
Home
Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were 25% lower in 2021 than in 2020, and no deaths occurred among patients who had been vaccinated against COVID-19, according to data presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | STEMI
In-Hospital Deaths in STEMI Patients With COVID-19 Drop in 2021

April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were ...

Home April 06, 2022
Home
Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (CHF) patients, announced results of a clinical study demonstrating the efficacy of its contact-free technology for the detection of pulmonary congestion at home.
News | Heart Failure
Study Demonstrates Efficacy of Contact-Free Tech for Pulmonary Congestion Detection at Home
April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure ...
Home April 06, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now